Somatic TET2 mutations in MDS are associated with advanced age, clonal hematopoiesis, and normal karyotype, suggesting that TET2 mutation is an aging-associated factor of hematopoietic cells (100). The gene discussed is TET2; the disease is myelodysplastic syndrome.